Variant report
Variant | esv1807572 |
---|---|
Chromosome Location | chr8:10469233-10470915 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:10466383..10469729-chr8:10471205..10473307,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35602868 | chr8:10469233-10469234 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs199911505 | chr8:10469234-10469235 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535712025 | chr8:10469243-10469244 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372020820 | chr8:10469251-10469252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370970032 | chr8:10469260-10469261 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555734400 | chr8:10469286-10469287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572249700 | chr8:10469287-10469288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376509567 | chr8:10469289-10469290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62490857 | chr8:10469292-10469293 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs372861090 | chr8:10469294-10469295 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs151054713 | chr8:10469299-10469300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs375957587 | chr8:10469312-10469313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs193225741 | chr8:10469313-10469314 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369772058 | chr8:10469315-10469316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372662692 | chr8:10469328-10469329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543510287 | chr8:10469329-10469330 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201666263 | chr8:10469339-10469340 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs57819090 | chr8:10469340-10469341 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs185177994 | chr8:10469346-10469347 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs377368052 | chr8:10469347-10469348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542094183 | chr8:10469351-10469352 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190077685 | chr8:10469370-10469371 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373602710 | chr8:10469381-10469382 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs377751683 | chr8:10469422-10469423 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs267601691 | chr8:10469426-10469427 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371254732 | chr8:10469429-10469430 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529460241 | chr8:10469434-10469435 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73662876 | chr8:10469436-10469437 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs370521287 | chr8:10469437-10469438 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547631676 | chr8:10469451-10469452 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181556707 | chr8:10469454-10469455 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200833270 | chr8:10469462-10469463 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373894974 | chr8:10469463-10469464 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367955605 | chr8:10469481-10469482 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533239961 | chr8:10469487-10469488 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372077597 | chr8:10469496-10469497 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs201625937 | chr8:10469530-10469531 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142446035 | chr8:10469533-10469534 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs202214615 | chr8:10469534-10469535 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372099332 | chr8:10469539-10469540 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200963001 | chr8:10469547-10469548 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146670053 | chr8:10469559-10469560 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200854414 | chr8:10469560-10469561 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200474804 | chr8:10469580-10469581 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372145840 | chr8:10469588-10469589 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375370418 | chr8:10469597-10469598 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369395204 | chr8:10469605-10469606 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373284948 | chr8:10469619-10469620 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs199628229 | chr8:10469625-10469626 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570063689 | chr8:10469632-10469633 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Gastric cancer | 21811585 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:10451800-10490000 | Weak transcription | Right Atrium | heart |
2 | chr8:10468200-10470800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr8:10469400-10470200 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
4 | chr8:10469400-10470400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |